LRVHealth

LRVHealth is a Boston-based venture capital firm founded in 2000 with additional offices in Marlborough and Amherst, Massachusetts. It concentrates on technology and healthcare investments across seed, early, and growth stages, including Series A and Series B rounds. The firm backs software, software-as-a-service, digital health, healthcare information technology, technology-enabled services, medical devices, diagnostics, and biotechnology, typically investing between $0.5 million and $5 million and often pursuing co-investments. While it seeks opportunities in the United States, it has a regional emphasis on Massachusetts. LRVHealth combines capital with operating experience and industry insight to help portfolio companies grow. It positions itself as an Inside Healthcare network, linking providers, payers, and vendors to identify and adopt innovative solutions addressing the industry's needs. Exits are commonly achieved through trade sales. The firm seeks to support early healthcare and tech-enabled companies by providing strategic guidance, market access, and operational support alongside capital.

Yoola Adeniji

Associate

William Cowen

General Partner

Lise Courtney D'Amico

Senior Associate

Keith Figlioli

Managing Partner

Joshua Flum JD

Managing Partner

Past deals in Personal Health

LucyRx

Seed Round in 2025
LucyRx is a pharmacy benefit manager (PBM) that aims to revolutionize prescription care. It offers a comprehensive suite of services, including personalized prescription management, transparent pricing, optimized health plans, 24/7 assistance, medication advice, and health wellness tips. By providing enhanced disclosure and simplifying claims processing, LucyRx addresses market gaps through its personal service model, ultimately helping clients better manage prescription drug costs.

Greater Good Health

Series A in 2023
Greater Good Health is a healthcare organization that expands access to value-based, holistic primary care through a nurse practitioner-led model. It partners with health plans to build primary care clinics in underserved communities and with risk-bearing organizations to deploy private-labeled clinical programs that enable the shift to value-based, outcomes-focused care. The company operates a nurse practitioner-powered platform that collaborates with provider groups to deliver patient-centered clinics, with the aim of improving outcomes, reducing costs, and delivering a high-quality patient experience for diverse populations.

Diana Health

Series B in 2023
Diana Health operates a network of contemporary women’s health practices that collaborate with hospitals to transform maternity and women’s healthcare delivery. The company offers a personalized care platform that integrates clinical services, education, and wellness support, aiming to improve clinical outcomes and streamline operations. Its model places women at the center of decision‑making, empowering them to prepare for childbirth and parenting in a way that aligns with their individual needs and preferences.

Upfront Healthcare Services

Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

KeyCare

Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Cleerly

Series C in 2022
Cleerly is a healthcare company developing digital care pathways to prevent heart attacks by establishing a new standard of care for coronary artery disease. The company combines clinical science with next-generation AI to deliver actionable insights across the heart care pathway, including a non-invasive platform that quantifies and characterizes plaque buildup in heart arteries. Its solutions aim to help healthcare providers identify at-risk patients early and support cost-effective prevention, ultimately improving cardiovascular outcomes and delivering value to the health system.

Greater Good Health

Series A in 2022
Greater Good Health is a healthcare organization that expands access to value-based, holistic primary care through a nurse practitioner-led model. It partners with health plans to build primary care clinics in underserved communities and with risk-bearing organizations to deploy private-labeled clinical programs that enable the shift to value-based, outcomes-focused care. The company operates a nurse practitioner-powered platform that collaborates with provider groups to deliver patient-centered clinics, with the aim of improving outcomes, reducing costs, and delivering a high-quality patient experience for diverse populations.

Season Health

Series A in 2022
Season Health operates a food-as-medicine platform designed to support individuals with chronic conditions by offering personalized nutrition planning. The platform combines technology with guidance from registered dietitians to provide tailored meal recommendations for breakfast, lunch, and dinner based on users' nutritional needs, food preferences, and budgets. By utilizing clinicians' food prescriptions, Season Health enables consumers to select condition-specific meals that promote better health outcomes, facilitating a healthier lifestyle in a straightforward manner. This approach not only aids users in making informed dietary choices but also enhances their overall well-being.

Diana Health

Series A in 2022
Diana Health operates a network of contemporary women’s health practices that collaborate with hospitals to transform maternity and women’s healthcare delivery. The company offers a personalized care platform that integrates clinical services, education, and wellness support, aiming to improve clinical outcomes and streamline operations. Its model places women at the center of decision‑making, empowering them to prepare for childbirth and parenting in a way that aligns with their individual needs and preferences.

Genome Medical

Series C in 2021
Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Cleerly

Series B in 2021
Cleerly is a healthcare company developing digital care pathways to prevent heart attacks by establishing a new standard of care for coronary artery disease. The company combines clinical science with next-generation AI to deliver actionable insights across the heart care pathway, including a non-invasive platform that quantifies and characterizes plaque buildup in heart arteries. Its solutions aim to help healthcare providers identify at-risk patients early and support cost-effective prevention, ultimately improving cardiovascular outcomes and delivering value to the health system.

Current Health

Series B in 2021
Current Health Limited is a healthcare technology company based in Edinburgh, United Kingdom, that specializes in wearable devices for monitoring patient vitals. Founded in 2014 and originally known as Snap40 Limited, the company rebranded in December 2018. Current Health's devices are designed to measure critical health indicators such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, enabling early identification of potential health issues. Their patient monitoring platform facilitates the management of patients at home by collecting and analyzing data to detect and predict health deterioration. This allows patients to share daily activities, report symptoms, and complete structured questionnaires, ultimately helping healthcare providers reduce risks and costs associated with patient care.

Carevive Systems

Series C in 2021
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.

Upfront Healthcare Services

Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Genome Medical

Series B in 2020
Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Carevive Systems

Series C in 2020
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.

Genome Medical

Series B in 2019
Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Oculus Health

Series A in 2017
Oculus Health, Inc. operates a chronic care management platform designed to enhance the connection between healthcare providers and patients. Founded in 2014 and based in Irving, Texas, the company offers a comprehensive suite of services that includes shared care plans, access to medical assistants via online and phone support, and real-time monitoring of enrolled patients. Oculus Health integrates data from various healthcare sources, such as hospitals and laboratories, to facilitate seamless information exchange among care teams. The platform also features user-friendly web and mobile applications, remote monitoring capabilities, and patient engagement solutions. By providing transparent care plans, personalized health coaching, and a reminder system, Oculus Health aims to empower individuals in managing their health proactively and improving overall patient outcomes while supporting providers in navigating the evolving healthcare landscape.

Carevive Systems

Series B in 2016
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.

GetWellNetwork

Series B in 2005
GetWellNetwork, Inc. is a Bethesda, Maryland-based company that specializes in developing precision engagement software solutions aimed at enhancing patient involvement in the healthcare process. Founded in 1999 by Michael O’Neil Jr., the company provides a range of interactive tools tailored for hospitals, including the GetWell Patient Care solution, which integrates various resources to activate patient participation. Its offerings encompass digital check-in systems, entertainment options, and personalized education through a library of condition-specific content. The GetWellNetwork platform utilizes predefined workflows, known as Patient Pathways, to deliver educational materials and engage patients in their care journey. This approach facilitates real-time monitoring and documentation of patient progress, enabling healthcare providers to customize experiences based on individual needs. GetWellNetwork primarily serves healthcare providers, pediatric hospitals, and government organizations, striving to improve patient care outcomes through enhanced engagement and education.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.